Famor, Marilyn .

HRN: 11-96-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
CEFUROXIME 500MG (TAB)
10/08/2024
10/14/2024
IV
1.5g
Q8
Cs
Waiting Final Action 
10/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/08/2024
10/09/2024
IV
500mg
Q8
Cs Thickly Msaf
Waiting Final Action 
10/08/2024
CEFUROXIME 1.5GM (VIAL)
10/08/2024
10/09/2024
IV
1.5g
Q8
Cs Thickly Msaf
Waiting Final Action 
10/09/2024
CEFUROXIME 500MG (TAB)
10/09/2024
10/15/2024
PO
1 Tab
BID
Post Op Prophylaxis; Thickly MSAF
Waiting Final Action 
10/09/2024
METRONIDAZOLE 500MG (TAB)
10/09/2024
10/15/2024
PO
1 Tab
TID
Post Op Prophylaxis; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: